Skip to search formSkip to main contentSkip to account menu

RU 51599

Known as: RU-51599 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

niravoline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Sensitization to the motor effects of contingent infusions of heroin but not of κ agonist RU 51599
Abstract It has been postulated that behavioral sensitization could reflect drug-induced changes that are central to the… 
1998
1998
Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion.
It has recently been reported that kappa-opioid receptor agonists inhibit antidiuretic hormone secretion and promote water… 
1998
1998
Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential
Opioid peptides, through μ and δ receptors, play an important part in reward. In contrast, the role of κ receptors is more… 
1997
1997
Treatment of acute intracranial hypertension with RU 51599, a selective kappa opioid agonist.
RU 51599, a selective kappa opioid agonist which is a potent aquaretic, was studied for its effect on acute intracranial… 
1997
1997
Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
1997
1997
Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells.
Arginine vasopressin (AVP) is synthesized in the hypothalamus, stored in the posterior pituitary, and osmotic and non-osmotic… 
1995
1995
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)